Dare Bioscience, Inc. — Director's Dealing 2015

Dec 3, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2015-09-04

Reporting Person: Senderowicz Adrian (SVP, Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Nonqualified Stock Option (right to buy)	$4.71	2024-06-09	Common Stock (90000)		Direct

Footnotes

F1: The shares underlying this option vest as to 1/4th of the shares on the first anniversary of May 18, 2015 and as to an additional 1/48th of the original number of shares at the end of each month of continuous service thereafter.